| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| W Veling, J P Mackenbach, J van Os, H W Hoe. Cannabis use and genetic predisposition for schizophrenia: a case-control study. Psychological medicine. vol 38. issue 9. 2008-10-20. PMID:18485264. |
cannabis use may be a risk factor for schizophrenia. |
2008-10-20 |
2023-08-12 |
Not clear |
| W Veling, J P Mackenbach, J van Os, H W Hoe. Cannabis use and genetic predisposition for schizophrenia: a case-control study. Psychological medicine. vol 38. issue 9. 2008-10-20. PMID:18485264. |
we investigated whether cannabis use is associated with schizophrenia, and whether gene-environment correlation contributes to this association, by examining the prevalence of cannabis use in groups with different levels of genetic predisposition for schizophrenia. |
2008-10-20 |
2023-08-12 |
Not clear |
| John Rathbone, Hannele Variend, Hetal Meht. Cannabis and schizophrenia. The Cochrane database of systematic reviews. issue 3. 2008-10-15. PMID:18646115. |
cannabis and schizophrenia. |
2008-10-15 |
2023-08-12 |
Not clear |
| John Rathbone, Hannele Variend, Hetal Meht. Cannabis and schizophrenia. The Cochrane database of systematic reviews. issue 3. 2008-10-15. PMID:18646115. |
many people with schizophrenia use cannabis and its effects on the illness are unclear. |
2008-10-15 |
2023-08-12 |
Not clear |
| Kirsten R Müller-Vahl, Hinderk M Emric. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia. Expert review of neurotherapeutics. vol 8. issue 7. 2008-10-01. PMID:18590475. |
cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia. |
2008-10-01 |
2023-08-12 |
Not clear |
| Kirsten R Müller-Vahl, Hinderk M Emric. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia. Expert review of neurotherapeutics. vol 8. issue 7. 2008-10-01. PMID:18590475. |
highlighting the association between schizophrenia and cannabis sativa and the endogenous cannabinoid receptor system, respectively, two opposite aspects are of major relevance. |
2008-10-01 |
2023-08-12 |
Not clear |
| Rajiv Tandon, Matcheri S Keshavan, Henry A Nasralla. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophrenia research. vol 102. issue 1-3. 2008-09-30. PMID:18514488. |
environmental factors linked to a higher likelihood of developing schizophrenia include cannabis use, prenatal infection or malnutrition, perinatal complications, and a history of winter birth; the exact relevance or nature of these contributions is, however, unclear. |
2008-09-30 |
2023-08-12 |
Not clear |
| Lonneke J van Nimwegen, Lieuwe de Haan, Nico Jm van Beveren, Mischa van der Helm, Wim van den Brink, Don Linsze. Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 53. issue 6. 2008-09-17. PMID:18616861. |
effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. |
2008-09-17 |
2023-08-12 |
Not clear |
| Lonneke J van Nimwegen, Lieuwe de Haan, Nico Jm van Beveren, Mischa van der Helm, Wim van den Brink, Don Linsze. Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 53. issue 6. 2008-09-17. PMID:18616861. |
to examine whether subjective well-being and craving for cannabis were different in patients with schizophrenia or related disorders treated with either olanzapine or risperidone. |
2008-09-17 |
2023-08-12 |
Not clear |
| Aníbal Goldchluk, Luis Herbs. [Permanent psychiatric effects in former addicts to marijuana or stimulants]. Vertex (Buenos Aires, Argentina). vol 19. issue 77. 2008-09-04. PMID:18443664. |
the marijuana might induce permanent psychosis in subjects with vulnerability to schizophrenia or to psychosis. |
2008-09-04 |
2023-08-12 |
human |
| Stephen M Eggan, Takanori Hashimoto, David A Lewi. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Archives of general psychiatry. vol 65. issue 7. 2008-09-04. PMID:18606950. |
cannabis use is associated with both impaired cognitive functions, including working memory, and an increased risk of schizophrenia. |
2008-09-04 |
2023-08-12 |
Not clear |
| Martin Cohen, Nadia Solowij, Vaughan Car. Cannabis, cannabinoids and schizophrenia: integration of the evidence. The Australian and New Zealand journal of psychiatry. vol 42. issue 5. 2008-08-14. PMID:18473254. |
cannabis, cannabinoids and schizophrenia: integration of the evidence. |
2008-08-14 |
2023-08-12 |
Not clear |
| Martin Cohen, Nadia Solowij, Vaughan Car. Cannabis, cannabinoids and schizophrenia: integration of the evidence. The Australian and New Zealand journal of psychiatry. vol 42. issue 5. 2008-08-14. PMID:18473254. |
the aim is to assist clinicians to probe more deeply into the newly unfolding world of cannabinoid physiology and to critically evaluate the potential role of cannabis in the onset and persistence of cognitive impairments and psychosis in otherwise healthy users and in schizophrenia. |
2008-08-14 |
2023-08-12 |
Not clear |
| T Rubino, D Parolar. Long lasting consequences of cannabis exposure in adolescence. Molecular and cellular endocrinology. vol 286. issue 1-2 Suppl 1. 2008-07-11. PMID:18358595. |
the literature here summarized by use of experimental animal models, puts forward that heavy cannabis consumption in adolescence may induce subtle changes in the adult brain circuits ending in altered emotional and cognitive performance, enhanced vulnerability for the use of more harmful drugs of abuse in selected individuals, and may represent a risk factor for developing schizophrenia in adulthood. |
2008-07-11 |
2023-08-12 |
Not clear |
| Martin Desseilles, Fernand Mathot, Michel Desseille. Aripiprazole diminishes cannabis use in schizophrenia. The Journal of neuropsychiatry and clinical neurosciences. vol 20. issue 1. 2008-07-02. PMID:18305305. |
aripiprazole diminishes cannabis use in schizophrenia. |
2008-07-02 |
2023-08-12 |
Not clear |
| Srihari S Bangalore, Konasale M R Prasad, Debra M Montrose, Dhruman D Goradia, Vaibhav A Diwadkar, Matcheri S Keshava. Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. Schizophrenia research. vol 99. issue 1-3. 2008-05-27. PMID:18248793. |
cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. |
2008-05-27 |
2023-08-12 |
Not clear |
| Srihari S Bangalore, Konasale M R Prasad, Debra M Montrose, Dhruman D Goradia, Vaibhav A Diwadkar, Matcheri S Keshava. Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. Schizophrenia research. vol 99. issue 1-3. 2008-05-27. PMID:18248793. |
we examined gray matter alterations in first episode schizophrenia patients (fes) with cannabis use (fes+c; n=15) compared to fes without cannabis use (fes-c; n=24) and 42 healthy controls who did not use cannabis. |
2008-05-27 |
2023-08-12 |
Not clear |
| Monica Rais, Wiepke Cahn, Neeltje Van Haren, Hugo Schnack, Esther Caspers, Hilleke Hulshoff Pol, René Kah. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. The American journal of psychiatry. vol 165. issue 4. 2008-05-14. PMID:18281413. |
cerebral gray matter volume reductions have been found to progress over time in schizophrenia, with larger decreases related to poorer outcome, which has also been associated with cannabis use in schizophrenia patients. |
2008-05-14 |
2023-08-12 |
Not clear |
| Robert Freedma. Cannabis, inhibitory neurons, and the progressive course of schizophrenia. The American journal of psychiatry. vol 165. issue 4. 2008-05-14. PMID:18381910. |
cannabis, inhibitory neurons, and the progressive course of schizophrenia. |
2008-05-14 |
2023-08-12 |
Not clear |
| Lynn E DeLis. The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Current opinion in psychiatry. vol 21. issue 2. 2008-05-13. PMID:18332661. |
the effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? |
2008-05-13 |
2023-08-12 |
Not clear |